Hydroxychloroquine

Malaria in Adult and Pediatric Patients: ● Prophylaxis: Begin weekly doses 2 weeks prior to travel to the endemic area, continue weekly doses while in the endemic area, and continue the weekly doses for 4 weeks after leaving the endemic area: - Adults: 400 mg once a week - Pediatric patients ≥ 31 kg: 6.5 mg/kg up to 400 mg, once a week ● Treatment of Uncomplicated Malaria: See Full Prescribing Information (FPI) for complete dosing information.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Hydroxychloroquine sulfate tablets are contraindicated in patients with known hypersensitivity to 4-aminoquinoline compounds. Patients with hypersensitivity to 4-aminoquinoline compounds

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Cardiomyopathy and Ventricular Arrhythmias: Fatal or life-threatening cardiomyopathy and ventricular arrhythmias were reported. Retinal Toxicity: Irreversible retinal damage is related to cumulative dosage and treatment duration. Baseline retinal exam and exams during treatment are recommended. Serious Skin Reactions: Stevens Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis have been reported. Worsening of Psoriasis: Avoid in patients with psoriasis. Risks Associated with Use in Porphyria: Avoid in patients with porphyria.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

The following adverse reactions are described in greater detail in other sections: Cardiomyopathy and Ventricular Arrhythmias Retinal Toxicity Serious Skin Reactions Worsening of Psoriasis Risks Associated with Use in Porphyria Hematologic Toxicity Hemolytic Anemia Associated with G6PD Skeletal Muscle Myopathy or Neuropathy Neuropsychiatric Reactions Including Suicidality Hypoglycemia Renal Toxicity The following adverse…

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

95 products from 63 makers in the NepalDoc medicine catalog use this generic:

Showing 30 of 95 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Storage Dispense in a tight, light-resistant container as defined in the USP/NF. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F).

Storage information from the U.S. FDA-approved label.